H.R. 3160 119th Congress
PREVAIL Act
- Commerce
- Sponsor: Rep. Moran, Nathaniel [R-TX-1]
- Congress.gov ↗
Latest action, May 1, 2025: Referred to the House Committee on the Judiciary.
How the Senate voted
The Senate hasn't taken a roll call on this bill in the Congresses covered.
2 cosponsors
Sponsored by Rep. Moran, Nathaniel [R-TX-1] (Republican). Cosponsors by party, House members included:
- Democrats
- Republicans
- Independents
Cosponsors
2 D · 0 R
Referred to: House: Judiciary Committee
Who lobbied on it
Clients whose quarterly lobbying reports named it, each quarter.
The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.
6 reports
6 reports
AUTM
WARING FEDERAL STRATEGIES
6 reports
CISCO SYSTEMS INC
FRANKLIN SQUARE GROUP, LLC
6 reports
COUNCIL FOR INNOVATION PROMOTION (C4IP)
RADIUS ADVOCACY, LLC
6 reports
6 reports
HIGH TECH INVENTORS ALLIANCE
FRANKLIN SQUARE GROUP, LLC
6 reports
HIGH TECH INVENTORS ALLIANCE
TWINLOGIC STRATEGIES, LLP
6 reports
INNOVATION ALLIANCE
AKIN GUMP STRAUSS HAUER & FELD
6 reports
6 reports
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
AKIN GUMP STRAUSS HAUER & FELD
6 reports
QUALCOMM INCORPORATED
COVINGTON & BURLING LLP
6 reports
6 reports
All 25 of 37 clients
| Client | Lobbying firm | Reports | Reports totaling | From | To | Senate |
|---|---|---|---|---|---|---|
| AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION (AIPLA) | 6 | $60K | Q4 2025 | Q3 2026 | yes | |
| APPLE INC | 6 | $16.3M | Q4 2025 | Q3 2026 | yes | |
| ASSOCIATION FOR ACCESSIBLE MEDICINES | 6 | $4.9M | Q4 2025 | Q3 2026 | yes | |
| AUTM | WARING FEDERAL STRATEGIES | 6 | $120K | Q4 2025 | Q3 2026 | yes |
| CISCO SYSTEMS INC | FRANKLIN SQUARE GROUP, LLC | 6 | $0 | Q4 2025 | Q3 2026 | yes |
| COUNCIL FOR INNOVATION PROMOTION (C4IP) | RADIUS ADVOCACY, LLC | 6 | $0 | Q4 2025 | Q3 2026 | yes |
| GSK (FKA GLAXOSMITHKLINE INC.) | 6 | $8.1M | Q4 2025 | Q3 2026 | yes | |
| HIGH TECH INVENTORS ALLIANCE | FRANKLIN SQUARE GROUP, LLC | 6 | $420K | Q4 2025 | Q3 2026 | yes |
| HIGH TECH INVENTORS ALLIANCE | TWINLOGIC STRATEGIES, LLP | 6 | $140K | Q4 2025 | Q3 2026 | yes |
| INNOVATION ALLIANCE | AKIN GUMP STRAUSS HAUER & FELD | 6 | $480K | Q4 2025 | Q3 2026 | yes |
| NOVARTIS | 6 | $9.8M | Q4 2025 | Q3 2026 | yes | |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | AKIN GUMP STRAUSS HAUER & FELD | 6 | $0 | Q4 2025 | Q3 2026 | yes |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 6 | $51.6M | Q4 2025 | Q3 2026 | yes | |
| QUALCOMM INCORPORATED | COVINGTON & BURLING LLP | 6 | $0 | Q4 2025 | Q3 2026 | yes |
| SOFTWARE & INFORMATION INDUSTRY ASSOCIATION | SIIA | 6 | $7.9M | Q4 2025 | Q3 2026 | yes |
| UNITED FOR PATENT REFORM | TWINLOGIC STRATEGIES, LLP | 6 | $320K | Q4 2025 | Q3 2026 | yes |
| US INVENTOR | NEOWISE CORP. | 6 | $40K | Q4 2025 | Q3 2026 | yes |
| AMAZON.COM SERVICES LLC | 5 | $22.2M | Q4 2025 | Q3 2026 | yes | |
| AMGEN INC | 5 | $15.3M | Q4 2025 | Q3 2026 | yes | |
| BIOTECHNOLOGY INNOVATION ORGANIZATION | 5 | $9.4M | Q4 2025 | Q3 2026 | yes | |
| CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) | WHITMER & WORRALL, LLC | 5 | $250K | Q4 2025 | Q2 2026 | yes |
| CORNELL UNIVERSITY | 5 | $1.2M | Q4 2025 | Q3 2026 | yes | |
| COUNCIL FOR INNOVATION PROMOTION (C4IP) | ACG ADVOCACY | 5 | $0 | Q4 2025 | Q3 2026 | yes |
| THE CAMPAIGN FOR SUSTAINABLE RX PRICING | MEHLMAN CONSULTING, INC. | 5 | $450K | Q4 2025 | Q3 2026 | yes |
| CATERPILLAR INC | 4 | $5.5M | Q4 2025 | Q2 2026 | yes |